Ethics & Informed Consent: Randomised Controlled Trial (RCT) (Finland)

1. Ethical Principles & Legislative Framework

In research involving human participants, securing ethical clearance is a critical first step. For a Randomised Controlled Trial (RCT) being conducted in Finland, study designs must align with the primary regulatory legislation: Medical Research Act (488/1999). This statutory framework ensures participant welfare, confidentiality, and voluntary involvement are protected.

Administrative review and formal approval are managed by a local or regional National Advisory Board on Social Welfare and Health Care Ethics (ETENE). Researchers must secure full approval or a formal exemption certificate from this board before recruiting any participants or commencing data collection.

2. Study Design Elements & Reporting Integrity

For a Randomised Controlled Trial (RCT), the review board places significant focus on methodological transparency. The application must outline the research rationale, recruitment protocols, inclusion and exclusion criteria, and data protection measures.

Study Classification: High Risk (Interventional)

As an interventional design, RCTs require rigorous safety oversight, clear allocation concealment, and predefined emergency unblinding pathways.

To guarantee academic integrity and reproducibility, the study report and subsequent publications should follow the internationally recognised reporting standard: CONSORT statement.

3. Informed Consent & Information Sheet Guidelines

A robust participant information sheet and informed consent form are critical parts of the ethical application. Ensure your documentation incorporates the following components:

• Plain Language Explanations: Avoid complex medical or technical terminology. Ensure readability matches the general population.
• Voluntary Participation: Explicitly state that participation is entirely voluntary and that individuals can withdraw at any time without negative consequences.
• Confidentiality & Data Controls: Explain how participant data will be anonymised or pseudonymised, who will have access to it, and how long it will be securely retained under EU GDPR & Finnish Data Protection Act (Tietosuojalaki).
• Risk/Benefit Disclosure: Clearly list any potential risks, discomforts, or direct benefits associated with participation in the study.
• Ethics Board Contact Information: Provide the contact details of the reviewing National Advisory Board on Social Welfare and Health Care Ethics (ETENE) so participants can reach out if they have questions or concerns.

Research Ethics, Clinical Trials & Institutional Governance

Designing a study protocol for this Randomised Controlled Trial (RCT) in Finland requires addressing complex ethical considerations in research for human participants. When recruiting participants in Finland, investigators must implement strict safeguards for vulnerable populations research ethics. Prior to any intervention, subjects must sign a comprehensive research consent form outlining potential side effects and protocols. Depending on the protocol, some secondary screening phases may satisfy irb exempt research criteria to streamline approvals. Any wet-lab procedures must declare their containment ratings, keeping facilities at biosafety level 1 2 3 4 based on pathogen risk. All records and signed consent sheets must reside on secure local servers in Finland to protect patient privacy and comply with national guidelines.

4. Regulatory Checklist Table

To streamline your ethical review submission, use the structured alignment checklist below:

6. Frequently Asked Questions